| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An introduction to key concepts in health economics for haemophilia organisations
|
O'Mahony, Brian
|
|
2011
|
|
3-4 |
p. 129-160
|
artikel
|
| 2 |
Author Index Volume 16 (2014)
|
|
|
2014
|
|
3-4 |
p. 363-365
|
artikel
|
| 3 |
Author Index Volume 15 (2013)
|
|
|
2014
|
|
3-4 |
p. 195-196
|
artikel
|
| 4 |
Author Index Volume 17 (2015)
|
|
|
2016
|
|
3-4 |
p. 463-465
|
artikel
|
| 5 |
Challenges and opportunities related to health promotion in community pharmacies: Obstacles and professional perspectives
|
Real, J.P.
|
|
2014
|
|
3-4 |
p. 313-320
|
artikel
|
| 6 |
Chapter 7 - Asisted fertilization and constitutional rights: A question still open
|
Florio, Francesco Severino
|
|
2016
|
|
3-4 |
p. 431-445
|
artikel
|
| 7 |
Chapter 6 - Clinical trials and off-label use of drugs
|
Cavo, Giovanni Maria
|
|
2016
|
|
3-4 |
p. 409-430
|
artikel
|
| 8 |
Chapter 2 - Community intervention in the field of health and the European regulation of clinical trials on medicinal products for human use
|
De Angelis, Paolo
|
|
2016
|
|
3-4 |
p. 297-325
|
artikel
|
| 9 |
Chapter 4 - Competence and role of ethics committees in clinical trials
|
Buratin, Michele
|
|
2016
|
|
3-4 |
p. 351-370
|
artikel
|
| 10 |
Chapter 1 - Institutional profiles of clinical trials and its applications
|
Bottari, Carlo
|
|
2016
|
|
3-4 |
p. 289-296
|
artikel
|
| 11 |
Chapter 3 - Profit and non profit clinical trials
|
Lorenzetti, Diego
|
|
2016
|
|
3-4 |
p. 327-350
|
artikel
|
| 12 |
Chapter 5 - Regulation and control of drugs: Between prescriptive appriopriateness and limitation of public spending towards the goal of deregulating the pharmaceutical market
|
Agnello, Carmen
|
|
2016
|
|
3-4 |
p. 373-408
|
artikel
|
| 13 |
Chapter 8 - Scientific research and human reproduction: The prevalence of the embryo in the Italian legal system
|
Vitiello, Boris
|
|
2016
|
|
3-4 |
p. 447-461
|
artikel
|
| 14 |
Characteristics of judicialization of health in relation to drugs
|
Mercedes, Salamano
|
|
2014
|
|
3-4 |
p. 283-287
|
artikel
|
| 15 |
Control and protection tools of personal data in digital healthcare
|
Ferrandu, Giovanni
|
|
2018
|
|
3-4 |
p. 209-218
|
artikel
|
| 16 |
Digitalizing and collecting health data in Sweden
|
Barbieri, Paolo Nicola
|
|
2018
|
|
3-4 |
p. 235-245
|
artikel
|
| 17 |
Digitization and collection of health data in the EU Member States: A comparative perspective
|
Laus, Federico
|
|
2018
|
|
3-4 |
p. 219-233
|
artikel
|
| 18 |
Directive 2011/24/EU: The application of patients’ rights regarding cross-border healthcare
|
Lorenzetti, Diego
|
|
2018
|
|
3-4 |
p. 133-140
|
artikel
|
| 19 |
Drug's information and publicity: A challenge for the pharmaceutical legislation
|
Giraudo, Federico Javier
|
|
2014
|
|
3-4 |
p. 321-337
|
artikel
|
| 20 |
Economic tools for ensuring access to medicines in Latin American countries
|
Tobar, Federico
|
|
2014
|
|
3-4 |
p. 207-224
|
artikel
|
| 21 |
Electronic medical prescription
|
Cavo, Giovanni Maria
|
|
2018
|
|
3-4 |
p. 197-208
|
artikel
|
| 22 |
First Latin American's academies of pharmacy meeting declaration
|
|
|
2014
|
|
3-4 |
p. 363-364
|
artikel
|
| 23 |
Foreword
|
|
|
2016
|
|
3-4 |
p. 283-285
|
artikel
|
| 24 |
Generic and similar products in Latin American countries: Current aspects and perspectives on bioequivalence and biowaivers
|
Storpirtis, Sílvia
|
|
2014
|
|
3-4 |
p. 225-248
|
artikel
|
| 25 |
Healthcare information technology in Italy, critiques and suggestions for European digitalization
|
Tuzii, Jennifer
|
|
2018
|
|
3-4 |
p. 161-176
|
artikel
|
| 26 |
Herbal medicines in Brazil: Legal rules
|
Borges, Leonardo Luiz
|
|
2014
|
|
3-4 |
p. 277-281
|
artikel
|
| 27 |
How is Italian pharmacy changing and what is the new direction: A modern health post or a drug-store?
|
Cicconetti, Pierandrea
|
|
2011
|
|
3-4 |
p. 303-306
|
artikel
|
| 28 |
Iberoamerican pharmaceutical academies
|
Ramos-Cormenzana, Alberto
|
|
2014
|
|
3-4 |
p. 349-361
|
artikel
|
| 29 |
Induced innovation of the German Employees' Invention Act
|
Oehlrich, Marcus
|
|
2014
|
|
3-4 |
p. 127-135
|
artikel
|
| 30 |
Internationalisation of regulatory requirements
|
Juillet, Yves
|
|
2008
|
|
3-4 |
p. 369-382
|
artikel
|
| 31 |
Introduction
|
Oehlrich, Marcus
|
|
2014
|
|
3-4 |
p. 99-102
|
artikel
|
| 32 |
ISBT 128: An internationally standardized means to label cellular therapy products
|
Distler, Pat
|
|
2008
|
|
3-4 |
p. 421-430
|
artikel
|
| 33 |
Latin American pharmaceutical overview
|
Valverde, José Luis
|
|
2014
|
|
3-4 |
p. 179-206
|
artikel
|
| 34 |
Legal and Political Competitiveness for Pharmaceuticals
|
Oehlrich, Marcus
|
|
2014
|
|
3-4 |
p. 93-97
|
artikel
|
| 35 |
New challenges for the Coordination Group for Mutual recognition and Decentralised procedures
|
Hoog, Truus Janse-de
|
|
2008
|
|
3-4 |
p. 343-356
|
artikel
|
| 36 |
Orphan drugs and paediatric medicinal products
|
Sprecher, Franziska
|
|
2014
|
|
3-4 |
p. 173-194
|
artikel
|
| 37 |
Pharmaceuticals in Latin America
|
|
|
2014
|
|
3-4 |
p. 175-177
|
artikel
|
| 38 |
Pharmacologic-technical progress and the economics of growth
|
Heible, Christoph
|
|
2014
|
|
3-4 |
p. 103-125
|
artikel
|
| 39 |
Pharma R&D in Latin America
|
Sellés, Alberto J. Núñez
|
|
2014
|
|
3-4 |
p. 267-275
|
artikel
|
| 40 |
P.H.R. e Big Data. Some juridical considerations about the digital health perspectives
|
Donati, Daniele
|
|
2018
|
|
3-4 |
p. 177-195
|
artikel
|
| 41 |
Protection of privacy and cyber risk in healthcare
|
Finocchiaro, Giusella
|
|
2018
|
|
3-4 |
p. 121-123
|
artikel
|
| 42 |
Recent changes to the Czech legal framework of setting the prices of pharmaceuticals paid for by the system of public health insurance
|
Tomáš,
|
|
2008
|
|
3-4 |
p. 403-409
|
artikel
|
| 43 |
Regulatory issues on pharmacovigilance in Latin American countries
|
Olivera, María Eugenia
|
|
2014
|
|
3-4 |
p. 289-312
|
artikel
|
| 44 |
The Australian government's review of the plasma fractionation arrangements in Australia
|
Farrugia, Albert
|
|
2008
|
|
3-4 |
p. 383-402
|
artikel
|
| 45 |
The Electronic Health Record (EHR): Legal framework and issues about personal data protection
|
Califano, Licia
|
|
2018
|
|
3-4 |
p. 141-159
|
artikel
|
| 46 |
The European Electronic Health Record. Critics and future
|
Valverde, José Luis
|
|
2018
|
|
3-4 |
p. 247-257
|
artikel
|
| 47 |
The European regulatory framework in eHealth sector
|
Bottari, Carlo
|
|
2018
|
|
3-4 |
p. 125-132
|
artikel
|
| 48 |
The European Union's advanced therapies proposal: The rapporteur's perspective
|
Mikolášik, Miroslav
|
|
2008
|
|
3-4 |
p. 317-325
|
artikel
|
| 49 |
The impact of the new deontological code upon the pharmacist's activities in Romania
|
Crişan, Ofelia
|
|
2008
|
|
3-4 |
p. 411-420
|
artikel
|
| 50 |
The International Pharmacopoeia in the changing environment
|
Kopp, Sabine
|
|
2008
|
|
3-4 |
p. 357-368
|
artikel
|
| 51 |
The medicines situation in Chile: A critical appraisal from the academy
|
García, José Luis
|
|
2014
|
|
3-4 |
p. 339-348
|
artikel
|
| 52 |
The need of one International Statute for Medicinal Products
|
|
|
2008
|
|
3-4 |
p. 271-272
|
artikel
|
| 53 |
The practice of pharmaceutical patents
|
Cervantes, Patricia Parra
|
|
2014
|
|
3-4 |
p. 249-266
|
artikel
|
| 54 |
The Regulation of Orphan Medicines in the EU: Objectives reached and main challenges when facing the future
|
Westermark, Kerstin
|
|
2008
|
|
3-4 |
p. 327-342
|
artikel
|
| 55 |
Toward a global legal statute for medicinal products
|
Valverde, José Luis
|
|
2008
|
|
3-4 |
p. 273-315
|
artikel
|
| 56 |
Translational research in regenerative medicine: A translational gap
|
Matsuyama, Akifumi
|
|
2014
|
|
3-4 |
p. 163-172
|
artikel
|
| 57 |
U.S. healthcare reform and the pharmaceutical market: Projections from institutional history
|
Daemmrich, Arthur
|
|
2014
|
|
3-4 |
p. 137-162
|
artikel
|
Tijdschrift beschrijving